ASX:CSL CSL (CSL) Stock Price, News & Analysis → The Hidden Anchor Investment of the Elite Revealed (From Colonial Metals) (Ad) Free CSL Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume869,289 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield1.37%Price TargetN/A Stock AnalysisStock Analysis Get CSL alerts: Email Address Ad Weiss RatingsNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. About CSL Stock (ASX:CSL)CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.Read More Ad Weiss RatingsNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. CSL Stock News HeadlinesMay 29, 2024 | msn.comThis BMW Will Be the Best-Looking Car at Le MansMay 28, 2024 | foxnews.comUS, European nations seek increased vaccine production to protect workers exposed to bird fluMay 27, 2024 | finance.yahoo.comThe Trend Of High Returns At Carlisle Companies (NYSE:CSL) Has Us Very InterestedMay 24, 2024 | msn.comThe 2025 BMW M4 CS Asks, 'What CSL?'May 23, 2024 | msn.comCan CSL shares deliver market-beating returns for investors?May 22, 2024 | benzinga.comOptions Movement At Carlisle Companies: D. Christian Koch Exercises Worth $16.22MMay 20, 2024 | finance.yahoo.comNature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics’ COVID-19 VaccineMay 17, 2024 | msn.com2023 BMW M4 CSL First Drive: Takes Your Breath AwayMay 17, 2024 | msn.comCSL Recruitment 2024 For General Worker Posts: Check eligibility and application processMay 15, 2024 | finance.yahoo.comCarlisle Companies Incorporated (CSL)May 13, 2024 | finance.yahoo.comCarlisle Companies Incorporated's (NYSE:CSL) Stock Is Going Strong: Is the Market Following Fundamentals?May 13, 2024 | markets.businessinsider.comCiti Keeps Their Hold Rating on CSL (CMXHF)May 13, 2024 | msn.comBuy CSL shares for growing dividends and 'compelling long-term tailwinds'May 10, 2024 | msn.comWatch the M4 CS Become the Second-Fastest Production BMW at the NürburgringMay 9, 2024 | msn.comThis 3.5-litre BMW CSL once owned by Jay Kay is up for auctionMay 8, 2024 | msn.comThe 2025 BMW M4 CS Packs 543 HP, $123,500 MSRPMay 8, 2024 | msn.com2025 BMW M4 CS Revealed: Not Quite The CSL, But At Least You Can Get OneMay 8, 2024 | msn.comThe 2025 BMW M4 CS Is the Quickest Accelerating M4 of Them AllMay 7, 2024 | msn.com3 reasons CSL stock is a great long-term investmentMay 7, 2024 | msn.comAustralia's CSL tests 'dynamic pricing' of donor blood amid cost surgeMay 2, 2024 | markets.businessinsider.comAnalysts Offer Insights on Industrial Goods Companies: Carlisle Companies (CSL), Bluelinx Holdings (BXC) and Upwork (UPWK)May 2, 2024 | finance.yahoo.comCRITICAL IOT CONNECTIVITY EXPERTS, CSL, ARE DELIGHTED TO ANNOUNCE THE APPOINTMENT OF GREVILLE COE AS CHIEF COMMERCIAL OFFICERApril 30, 2024 | finance.yahoo.comMark Cuban Foundation and CSL Bring AI Bootcamp to Philadelphia TeensApril 30, 2024 | markets.businessinsider.comARS Pharma Submits Response For Neffy MAA To EMA's CHMP, Signs License Deal With CSL SeqirusApril 30, 2024 | sports.yahoo.comCSL Quick Six: Do the Panthers still need to add players from free agency?See More Headlines Receive CSL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/14/2019Ex-Dividend for 4/2 Dividend3/10/2024Dividend Payable4/02/2024Today6/03/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:CSL CUSIPN/A CIKN/A Webwww.csl.com.au Phone+61-3-93891911FaxN/AEmployees32,065Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$7.59 Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth1.29Net Income$2.47 billion Net Margins17.43% Pretax MarginN/A Return on Equity13.63% Return on Assets6.41% Debt Debt-to-Equity Ratio63.18 Current Ratio2.15 Quick Ratio1.68 Sales & Book Value Annual Sales$14.18 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow207.70 Book ValueA$35.56 per share Price / BookN/AMiscellaneous Outstanding Shares483,250,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.30 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. Paul F. McKenzie Ph.D. (Age 58)MD, CEO & Executive Director Comp: $4.15MMs. Joy Carolyn Linton B.Com. (Age 59)BComm, GAICD, Grad Dip AFI, Chief Financial Officer Comp: $3.09MMr. Mark DehringHead of Investor RelationsMr. Gregory Boss B.S. (Age 63)BS(Hons), J.D., Executive VP of Legal & General Counsel Comp: $1.65MChristina HickieSenior Manager of CommunicationsMs. Roanne ParryChief Human Resources OfficerDr. Karen Etchberger (Age 66)Executive Vice President of Quality & Business Services Comp: $1.56MMs. Jemimah BrennanHead of Communications - Asia PacificDr. Andrew D. Nash BSc (Hons) (Age 62)GAICD, Ph.D., Senior Vice President of Research Dr. William Mezzanotte M.D. (Age 65)M.P.H., Executive VP & Head of Research and Development Comp: $2.2MMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF45525 (CUR.TO)TSE:CUR60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFView All CompetitorsInsidersSamantha (Sam) LewisSold 114 sharesTotal: $32,189.95 ($282.37/share)Alison WatkinsSold 169 sharesTotal: $47,996.00 ($284.00/share)Megan ClarkBought 210 shares on 10/20/2023Total: $49,939.05 ($237.81/share)Paul McKenzieSold 44,095 sharesTotal: $10.51 M ($238.24/share)Paul McKenzieSold 3,120 sharesTotal: $839,560.80 ($269.09/share) CSL Stock Analysis - Frequently Asked Questions How were CSL's earnings last quarter? CSL Limited (ASX:CSL) released its earnings results on Wednesday, August, 14th. The company reported $4.24 EPS for the quarter, topping analysts' consensus estimates of $4.22 by $0.01. CSL had a net margin of 17.43% and a trailing twelve-month return on equity of 13.63%. How often does CSL pay dividends? What is the dividend yield for CSL? CSL declared a Interim dividend on Friday, March 8th. Shareholders of record on Tuesday, April 2nd will be given a dividend of 1.826 per share on Tuesday, April 2nd. This represents a dividend yield of 0.64%. The ex-dividend date of this dividend is Sunday, March 10th. This is a positive change from the stock's previous Interim dividend of A$1.55. Read our dividend analysis for CSL. Is CSL a good dividend stock? CSL (ASX:CSL) pays an annual dividend of A$3.81 per share and currently has a dividend yield of 1.37%. The dividend payout ratio is 50.20%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for CSL. What other stocks do shareholders of CSL own? Based on aggregate information from My MarketBeat watchlists, some companies that other CSL investors own include BHP Group (BHP), Commonwealth Bank of Australia (CBA), Cochlear (COH), ResMed (RMD), Telstra Group (TLS), Woodside Petroleum (WPL), Altium (ALU), Afterpay (APT), Appen (APX) and Berkshire Hathaway (BRK.B). This page (ASX:CSL) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersAlert: Your Bank is Dying – Act Now or Lose Everything!Priority GoldDoes this make you sick?Allegiance GoldThe Only Energy Play You Should Be Looking AtWealthpin ProShocking $16T Elon Musk Crypto LeakCrypto 101 MediaNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsBiden replacement revealed?Paradigm PressHistoric Crash Could Wipe Away Your 401k (Govt Debt Explosion)Birch Gold[Webinar] Understanding Covered CallsOIC Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CSL Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.